Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations : USA Observational Cohort Study Using the Clinformatics™ Health Claims Database

Thomas, Vicky; Gefen, Eran; Gopalan, Gokul; Mares, Rafael; McDonald, Rosie; Ming, Simon Wan Yau; Price, David B.

Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations : USA Observational Cohort Study Using the Clinformatics™ Health Claims Database

Files

10.1007_2Fs41030_017_0041_7.pdf (840.29 KB)

Date

2017-06

Authors

Citation

Thomas, V, Gefen, E, Gopalan, G, Mares, R, McDonald, R, Ming, S W Y & Price, D B 2017, 'Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations : USA Observational Cohort Study Using the Clinformatics™ Health Claims Database', Pulmonary Therapy, vol. 3, no. 1, pp. 187-205. https://doi.org/10.1007/s41030-017-0041-7